DCVC BIO
DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches. Advances in genetic sequencing, artificial intelligence, and automation are converging to transform existing life sciences technologies and speed the development of new ones. The firm is looking for companies affecting deep technological change in synthetic biology, medicine, and agriculture. DCVC Bio was founded in 2018 and is based in San Francisco, California, United States.
DCVC BIO
Industry:
AgTech Biotechnology Life Science
Founded:
2018-01-01
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-20 | Auron Therapeutics | DCVC Bio investment in Series A - Auron Therapeutics | 48 M USD |
| 2022-07-01 | Sabanto | DCVC Bio investment in Series A - Sabanto | 17 M USD |
| 2022-04-19 | Unlearn.AI | DCVC Bio investment in Series B - Unlearn.AI | 50 M USD |
| 2022-03-08 | Creyon Bio | DCVC Bio investment in Series A - Creyon Bio | 40 M USD |
| 2022-02-23 | Plexium | DCVC Bio investment in Series B - Plexium | 102 M USD |
| 2021-12-09 | Totus Medicines | DCVC Bio investment in Series A - Totus Medicines | 40 M USD |
| 2021-10-06 | CH4 Global | DCVC Bio investment in Series A - CH4 Global | 13 M USD |
| 2021-09-23 | GenEdit | DCVC Bio investment in Series A - GenEdit | 26 M USD |
| 2021-07-19 | Frontier Medicines | DCVC Bio investment in Series B - Frontier Medicines | 88.5 M USD |
| 2021-07-15 | Stemson Therapeutics | DCVC Bio investment in Series A - Stemson Therapeutics | 15 M USD |
More informations about "DCVC Bio"
DCVC Bio - Crunchbase Investor Profile & Investments
DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches. Advances in genetic sequencing, artificial intelligence, and automation are converging to transform existing life …See details»
DCVC | Home
DCVC closes $700 million+ in new funds for a healthier planet and healthier lives; releases second-annual Deep Tech Opportunities Report and first-annual DCVC Climate Impact Report …See details»
DCVC Bio III closes at $ 400 million
Sep 30, 2024 DCVC Bio was founded in 2018 to exploit the promise of AI-enabled platforms to discover new medicines and catalyze a range of other biological breakthroughs. We aimed to …See details»
DCVC Bio - LinkedIn
DCVC Bio invests in early stage deep tech startups in the life sciences. These include therapeutics platforms, companies improving agriculture and food systems, and industrial biotechnologies. We ...See details»
DCVC Bio - Investments, Portfolio & Company Exits - Crunchbase
Sep 17, 2024 DCVC Bio 's most notable exits include AbCellera and BioPhero. Which industries has this organization had the most exits in? Show . AbCellera AbCellera is an antibody …See details»
DCVC Bio Closes $400 Million Fund III to Accelerate Breakthroughs …
Oct 1, 2024 Looking Ahead with DCVC Bio III With DCVC Bio III, the firm will continue to back companies pushing the boundaries of life sciences. Current investments include Radionetics …See details»
DCVC Bio Announces $400M Fund Formation | Gunderson …
Sep 30, 2024 Gunderson Dettmer represented client DCVC Bio in the formation of its $400 million fund, DCVC Bio III. DCVC Bio differentiates itself from other biotechnology venture …See details»
DCVC Bio investment portfolio - PitchBook
DCVC Bio has made numerous investments in companies like Syntax Bio, NILO Therapeutics, and Latus Bio within the Biotechnology and Drug Discovery industries. What has DCVC Bio invested in recently? DCVC Bio's latest …See details»
Kiersten Stead, Managing Partner of DCVC Bio, on …
Oct 26, 2022 DCVC is a venture capital firm based in the West Coast that focuses on deep tech investing, and has over $3B in assets under management. DCVC Bio is the bio focused fund of DCVC, where Kiersten…See details»
DCVC | Life sciences and Deep Tech: The next set of …
Today we’re excited to announce the close of DCVC Bio II, a $ 350 million early stage fund raised entirely during the global pandemic and focused on Deep Tech-enabled life sciences companies in human therapeutics, agriculture and …See details»
DCVC Bio, a Silicon Valley VC firm, launches a $400 million fund
Sep 30, 2024 The announcement makes DCVC Bio one of a select number of biotech VCs to raise new pools of capital this year. Biotech investors raised 53 funds last year and 85 funds in …See details»
DCVC Bio - Funding, Financials, Valuation & Investors - Crunchbase
DCVC Bio has raised a total of $561M across 2 funds, their latest being DCVC Bio I. Funds Raised. Edit Funds Raised Section. Number of Funds 2. Total Fund Raised $561M. DCVC Bio …See details»
DCVC Bio III: Fund Performance - PitchBook
Apr 30, 2024 DCVC Bio III's latest investment was on 30-Apr-2024 in Latus Bio, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover …See details»
DCVC Bio II: Fund Performance - PitchBook
Jan 8, 2024 DCVC Bio II is a 2020 vintage venture capital fund managed by DCVC Bio. The fund is located in San Francisco, California, and will invest in the US, Western Europe. The …See details»
DCVC To Raise $250 Million For Bio-Focused Fund, Incorporating …
Apr 20, 2018 According to a filing with the U.S. Securities and Exchange Commission (SEC), Data Collective is set to raise up to $250 million for a new fund, “DCVC Bio, L.P.” No capital …See details»
DCVC | DCVC 2024 Q3 update
Oct 1, 2024 Greetings, friends of DCVC! We’ve hit the ground running after a productive summer. We are delighted to announce over $ 700 million in fresh funding across DCVC Bio …See details»
Decoding Biotech: A Deep Dive into AI and Platform Technologies
Jan 3, 2024 DCVC Bio is really focused on computational biology. They do everything from therapeutics to AG. And so Kirsten is a scientist investor. She's focused on developing deep …See details»
Kiersten Stead - Managing Partner - DCVC Bio - Crunchbase
Kiersten Stead is a Managing Partner at DCVC Bio. Prior to DCVC Bio, Kiersten was an Investment Director at Monsanto Growth Ventures (MGV), the Venture Capital arm of …See details»
DCVC Bio - Contacts, Employees, Board Members, Advisors
DCVC Bio has 3 current employee profiles, including Partner Eric Shiozaki. Contacts. Edit Contacts Section. Job Department. Protected Content. Finance and Administration. Non …See details»